Novo Nordisk
NVO
#27
Rank
S$448.16 B
Marketcap
$100.82
Share price
-2.01%
Change (1 day)
-42.08%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): S$25.26 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are S$41.89 Billion. , an increase over its 2023 earnings that were of S$20.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 S$25.35 B22.75%
2023 S$20.65 B57.64%
2022 S$13.10 B5.35%
2021 S$12.43 B12.47%
2020 S$11.05 B13.07%
2019 S$9.78 B-3.35%
2018 S$10.11 B1.79%
2017 S$9.94 B4.52%
2016 S$9.51 B9.42%
2015 S$8.69 B8.24%
2014 S$8.03 B3.45%
2013 S$7.76 B19.02%
2012 S$6.52 B15.21%
2011 S$5.66 B17.71%
2010 S$4.80 B24.78%
2009 S$3.85 B10.62%
2008 S$3.48 B55.97%
2007 S$2.23 B7.07%
2006 S$2.08 B18.18%
2005 S$1.76 B11.33%
2004 S$1.58 B
2002 S$1.01 B-14.39%
2001 S$1.18 B-52.82%
2000 S$2.52 B250%
1999 S$0.72 B31.21%
1998 S$0.54 B34.31%
1997 S$0.40 B11.46%
1996 S$0.36 B9.03%
1995 S$0.33 B-3.15%
1994 S$0.34 B-0.67%
1993 S$0.34 B45.38%
1992 S$0.24 B-13.81%
1991 S$0.27 B37.12%
1990 S$0.20 B-0.79%
1989 S$0.20 B26.2%
1988 S$0.16 B24.97%
1987 S$0.13 B-0.9%
1986 S$0.13 B-7.78%
1985 S$0.14 B24.87%
1984 S$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$14.87 B-41.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.97 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$11.22 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.63 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France